+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Relpax"

From
Relpax - API Insight, 2022 - Product Thumbnail Image

Relpax - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Relpax- Drug Insight, 2019 - Product Thumbnail Image

Relpax- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Relpax is a brand of analgesic drug used to treat migraine headaches. It belongs to a class of drugs known as triptans, which are selective serotonin receptor agonists. Relpax works by narrowing the blood vessels around the brain, reducing inflammation and relieving pain. It is available in tablet form and is taken orally. It is usually taken at the first sign of a migraine attack, and can be taken with or without food. It is not recommended for use in children under 18 years of age. Relpax is a popular choice for migraine sufferers due to its effectiveness and convenience. It is generally well tolerated, with few side effects. Common side effects include nausea, dizziness, and fatigue. Companies in the Relpax market include Pfizer, Merck, and GlaxoSmithKline. Show Less Read more